Italy’s health regulator is reportedly seeking damages worth nearly$2 billion from three of the world’s largest pharmaceutical firms for their repeated antitrust violations and subsequent harm on the nation’s health industry.
According to reports, the nation’s health ministry announced Wednesday it is seeking about $1.6 billion in damages from Novartis and Roche for anticompetitive action taken between 2012 and 2014; it wants another $19 million from Pfizer.
In its statement, the regulator cited various antitrust rulings against the pharmaceutical firms that lead to “considerable damage” imposed on Italy’s health service.
The announcement follows two months after the nation’s antirust regulator found Roche and Novartis of striking an unfair pay-for-delay deal, which saw Novartis pay Roche to prevent the release of a less expensive drug. The companies were fined $254.2 million.
The companies denied any wrongdoing and said they plan to appeal the decision.
Italy’s highest administrative court ruled last February that Pfizer abused its marked dominance regarding another drug.
The violations are now the reason health officials are calling for the companies to pay up, claiming the harm done to competition by the alleged behavior has lead to harm to national healthcare.
Full content: Business Recorder
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
T-Mobile Faces Class-Action Lawsuit Over Sprint Merger After Appeal Denied
May 16, 2024 by
CPI
Google Faces Backlash Over Introduction of AI-Generated Summaries in Searches
May 16, 2024 by
CPI
CMA Launches Phase 2 Probe into AlphaTheta’s Acquisition of Serato
May 16, 2024 by
CPI
NFL Executive Escapes Testifying in High-Stakes Trial Over Televised Games
May 16, 2024 by
CPI
EU Consumers Lodge Complaint Against Chinese Retailer Temu Over Content Rules Breach
May 16, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Ecosystems
May 9, 2024 by
CPI
Mapping Antitrust onto Digital Ecosystems
May 9, 2024 by
CPI
Ecosystems and Competition Law: A Law and Political Economy Approach
May 9, 2024 by
CPI
Ecosystem Theories of Harm: What is Beyond the Buzzword?
May 9, 2024 by
CPI
Open Ecosystems: Benefits, Challenges, and Implications for Antitrust
May 9, 2024 by
CPI